Mar 11, 2019 7:00am EDT NeoGenomics Launches Immuno-Oncology Companion Diagnostic Test for Triple Negative Breast Cancer in Conjunction with FDA Approval for TECENTRIQ(R)
Mar 07, 2019 4:50pm EST NeoGenomics To Present At 39th Annual Cowen and Company Health Care Conference
Feb 19, 2019 7:00am EST NeoGenomics Reports Record Revenue of $76 Million with 17% Organic Revenue Growth in the Fourth Quarter
Jan 28, 2019 7:00am EST NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2018 Earnings Release for February 19, 2019
